CytoSorbents Announces Kathleen P. Bloch To Resume as Full-Time Chief Financial Officer

PRINCETON, N.J., Sept. 19, 2023 -- CytoSorbents Corporation , a critical care therapy leader commercializing its CytoSorb® blood purification technology to treat cytokine storm and deadly...

Related Keywords

Canada ,United States ,Canadian ,Phillip Chan ,Kathleenp Bloch ,Alexander Damico ,Kathleen Bloch ,Human Services ,European Union ,Cytosorbents Corporation ,Facebook ,National Institutes Of Health ,Us Army ,Health Canada ,Material Command ,Us Air ,Blood Institute ,Twitter ,Us Department Of Health ,National Heart ,Sorbents Corporation ,Chief Financial Officer ,Chief Executive Officer ,Chief Financial ,Use Authorization ,Timely Antithrombotic Removal ,Device Designations ,National Institutes ,Operations Command ,Air Force Material Command ,Private Securities Litigation Reform Act ,Annual Report ,Quarterly Reports ,Sorbents Contact ,Markets ,